Adlai Nortye Group Ltd. (ANL) shareholders
Close on Nov 17, 2026Market cap $379.20MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Yang Lu Joint filing with Archer Future Limited (15.30%), Sagitta Future Limited (15.30%) | 19,390,000 | 17.50% | 13G (passive) | Dec 31, 2023 |
| Nimish Shah Joint filing with Venrock Healthcare Capital Partners III, L.P. (6.10%), VHCP Co-Investment Holdings III, LLC (6.10%) and 4 more | 9,638,193 | 6.10% | 13G (passive) | Feb 4, 2026 |
| ANL Talent Limited | 9,300,000 | 7.75% | 13G (passive) | Dec 31, 2025 |
| Nortye Talent Limited | 9,000,000 | 8.10% | 13G (passive) | Dec 31, 2023 |
| ATCG Holdings Limited Joint filing with Hui Shao (6.20%) | 6,868,657 | 6.20% | 13G (passive) | Dec 31, 2023 |
| Nortye International Limited | 6,000,000 | 5.40% | 13G (passive) | Dec 31, 2023 |
| Unique Mark Ventures Ltd Joint filing with Fine Process Limited (6.14%) | 5,750,790 | 6.14% | 13G (passive) | Mar 31, 2025 |
| Cormorant Asset Management, LP Joint filing with Bihua Chen (6.77%) | 3,978,229 | 6.77% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ANL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 3,978,229 | 3.32% | $45.75M | +1,080,372 | 2.34% |
| VR Adviser, LLC | 3,212,731 | 2.68% | $36.95M | – | 1.12% |
| Balyasny Asset Management L.P. | 3,061,668 | 2.55% | $35.21M | +2,183,822 | 0.04% |
| Point72 Asset Management, L.P. | 2,140,664 | 1.78% | $24.62M | New | 0.03% |
| Mpm Bioimpact LLC | 1,936,291 | 1.61% | $22.27M | New | 1.36% |
| Perceptive Advisors LLC | 1,793,190 | 1.49% | $20.62M | New | 0.31% |
| Casdin Capital, LLC | 1,250,000 | 1.04% | $14.38M | +711,539 | 0.72% |
| ADAR1 Capital Management, LLC | 1,017,805 | 0.85% | $11.70M | +899,896 | 0.54% |
| Octagon Capital Advisors LP | 934,716 | 0.78% | $10.75M | New | 0.97% |
| Millennium Management LLC | 807,832 | 0.67% | $9.29M | +126,057 | 0.00% |
| Braidwell LP | 795,214 | 0.66% | $9.14M | New | 0.34% |
| Squadron Capital Management LLC | 764,876 | 0.64% | $8.80M | −500,355 | 2.73% |
| Eventide Asset Management, LLC | 718,747 | 0.60% | $8.27M | New | 0.11% |
| Superstring Capital Management LP | 552,501 | 0.46% | $6.35M | +137,649 | 4.01% |
| Adage Capital Partners Gp, L.L.C. | 538,461 | 0.45% | $6.19M | – | 0.01% |
| Woodline Partners LP | 455,733 | 0.38% | $5.24M | +246,474 | 0.02% |
| Soleus Capital Management, L.P. | 405,523 | 0.34% | $4.66M | New | 0.16% |
| Freestone Grove Partners LP | 397,446 | 0.33% | $4.57M | New | 0.03% |
| Boone Capital Management LLC | 258,390 | 0.22% | $2.97M | New | 0.70% |
| DAFNA Capital Management LLC | 239,553 | 0.20% | $2.75M | New | 0.53% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 42 | 26M | 22.1% | 22 / 9 | 7 / 6 | 16M | 1M |
| Q1 2026 | 26 | 12M | 9.7% | 22 / 2 | 0 / 1 | 12M | 0M |
| Q4 2025 | 5 | 0M | 0.0% | 2 / 1 | 1 / 2 | 0M | 0M |
| Q3 2025 | 5 | 0M | 0.0% | 2 / 0 | 3 / 1 | 0M | 0M |
| Q2 2025 | 4 | 0M | 0.0% | 2 / 2 | 0 / 2 | 0M | 0M |
| Q1 2025 | 4 | 0M | 0.0% | 1 / 1 | 1 / 0 | 0M | 0M |
| Q4 2024 | 3 | 0M | 0.0% | 0 / 0 | 3 / 0 | 0M | 0M |
| Q3 2024 | 3 | 0M | 0.1% | 1 / 2 | 0 / 1 | 0M | 0M |
| Q2 2024 | 3 | 0M | 0.0% | 0 / 1 | 1 / 0 | 0M | 0M |
| Q1 2024 | 3 | 0M | 0.1% | 0 / 0 | 1 / 0 | 0M | 0M |
| Q4 2023 | 3 | 0M | 0.1% | 1 / 1 | 1 / 1 | 0M | 0M |
| Q3 2023 | 3 | 0M | 0.0% | 3 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
4 funds held ANL in Q2 2026, 6% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ANL | Value | % of fund | As of |
|---|---|---|---|---|---|
| Eventide Healthcare & Life Sciences Fund | 718,747 | 0.60% | $8.27M | 0.46% | Jun 30, 2026 |
| Tema Oncology ETF | 44,354 | 0.04% | $529.59K | 0.30% | May 31, 2026 |
| Virtus Biotech Clinical Trials Etf | 30,117 | 0.03% | $391.52K | 0.84% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 11,133 | 0.01% | $132.93K | 0.00% | May 31, 2026 |
| Ultrachina Profund | 1,156 | 0.00% | $15.03K | 0.07% | Jul 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -500 | -0.00% | -$5.75K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Yang Lu | CEO, Director, 10% owner | 17,089,990 | 14.24% | May 21, 2026 |
| Xiaofeng Ye | CFO | 147,788 | 0.12% | Aug 26, 2026 |
| Archie Tse | President, Head of R&D | 50,000 | 0.04% | May 20, 2026 |
| Kaiyang Tang | President,Adlai Nortye USA INC | – | – | May 14, 2026 |
| Ping Ji | Director | 121,453 | 0.10% | Oct 1, 2026 |
| Lars Erik Birgerson | Director | 166,668 | 0.14% | Aug 4, 2026 |
| Roger Sawhney | Director | 9,838 | 0.01% | Jul 15, 2026 |
| Alan Ming Lun Tse | Director | – | – | May 28, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ping Ji Director | Sep 30, 2026 | Sale | −5,000 | $15.95 | $79.75K | 121,453 |
| Ping Ji Director | Sep 30, 2026 | Sale | −5,000 | $16.03 | $80.15K | 126,453 |
| Ping Ji Director | Sep 29, 2026 | Sale | −214 | $15.77 | $3.37K | 131,453 |
| Ping Ji Director | Sep 22, 2026 | Sale | −5,000 | $16.63 | $83.15K | 131,667 |
| Xiaofeng Ye CFO | Aug 26, 2026 | Sale | −5,667 | $14.25 | $80.75K | 147,757 |
| Xiaofeng Ye CFO | Aug 24, 2026 | Sale | −6,000 | $13.98 | $83.88K | 153,424 |
| Ping Ji Director | Jun 10, 2026 | Other | +136,667 | – | – | 136,667 |
| Yang Lu CEO, Director, 10% owner | May 13, 2026 | Sale | −10 | $13.18 | $132 | 99,990 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Adlai Nortye's stock actually held short. Settlement fails (shares not delivered on time) peaked at 13,035 shares on Sep 9, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Ping Ji Director | Sep 18, 2026 | 80,000 | $1.22M | Sep 29, 2026 | Distribution from the PECO Innovation Trust |
See a number that looks wrong?